Wednesday, June 19, 2013
Submit a News Story
Prosonix Appoints Cécile Miles as Chief Business Officer
Published: Tuesday, February 12, 2013
Last Updated: Tuesday, February 12, 2013
Appointment significantly strengthens corporate and commercial development experience in the generics and speciality pharmaceutical markets.
Full access to this article is for registered users only.
is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.
Expelled DNA that Traps Toxins May Backfire in Obese
The body’s most powerful immune cells may have a radical way of catching their prey that could backfire on people who are overweight.
Developing Cancer Drugs
Researchers find therapeutic potential in ‘undruggable’ target.
Memory-Boosting Chemical Is Identified in Brains of Mice
UCSF cell biologists find molecule targets a key biological pathway.
Aspirin May Fight Cancer by Slowing DNA Damage
UCSF-led study of patients with pre-cancerous conditions probed NSAID effects on mutation rate.
Key Protein is Linked to Circadian Clocks, Helps Regulate Metabolism
Study sheds light on molecular basis for metabolic health and disease.
Yale Research Projects Exploring New Uses for Failed Drugs get NIH Funding
Two Yale School of Medicine research programs are among nine nationally to receive grants under a new federal program.
Researchers Demonstrate Use of Stem Cells to Analyze Diabetes Causes and Treatment
Scientists are using patient-specific stem cells to correct deficient insulin-producing cells.
Precocious Puberty Gene Found
Broad Institute scientists have discovered a gene which causes some cases of early-onset puberty.
Developmental Protein Plays Role in Spread of Cancer
A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating metastasis.
Scientists Coax Brain to Regenerate Cells Lost in Huntington’s Disease
The study appears in the journal Cell Stem Cell.
Advertise On This Site
Terms & Conditions
©2013 Technology Networks
, all rights reserved.